486 related articles for article (PubMed ID: 36101460)
1. Identifying General Tumor and Specific Lung Cancer Biomarkers by Transcriptomic Analysis.
Otálora-Otálora BA; Osuna-Garzón DA; Carvajal-Parra MS; Cañas A; Montecino M; López-Kleine L; Rojas A
Biology (Basel); 2022 Jul; 11(7):. PubMed ID: 36101460
[TBL] [Abstract][Full Text] [Related]
2. Joint Transcriptomic Analysis of Lung Cancer and Other Lung Diseases.
Otálora-Otálora BA; Florez M; López-Kleine L; Canas Arboleda A; Grajales Urrego DM; Rojas A
Front Genet; 2019; 10():1260. PubMed ID: 31867044
[No Abstract] [Full Text] [Related]
3. Identification of the Transcriptional Regulatory Role of RUNX2 by Network Analysis in Lung Cancer Cells.
Otálora-Otálora BA; González Prieto C; Guerrero L; Bernal-Forigua C; Montecino M; Cañas A; López-Kleine L; Rojas A
Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551878
[TBL] [Abstract][Full Text] [Related]
4. Lung Cancer Gene Regulatory Network of Transcription Factors Related to the Hallmarks of Cancer.
Otálora-Otálora BA; López-Kleine L; Rojas A
Curr Issues Mol Biol; 2023 Jan; 45(1):434-464. PubMed ID: 36661515
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
6. Identification key genes, key miRNAs and key transcription factors of lung adenocarcinoma.
Li J; Li Z; Zhao S; Song Y; Si L; Wang X
J Thorac Dis; 2020 May; 12(5):1917-1933. PubMed ID: 32642095
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer.
Zhou M; Chen Y; Gu X; Wang C
Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144
[No Abstract] [Full Text] [Related]
8. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
Deng JL; Xu YH; Wang G
Front Genet; 2019; 10():695. PubMed ID: 31428132
[No Abstract] [Full Text] [Related]
9. Identification of core miRNAs and regulatory pathways in breast cancer by integrated bioinformatics analysis.
Feng H; Song Z
Mol Omics; 2021 Apr; 17(2):277-287. PubMed ID: 33462573
[TBL] [Abstract][Full Text] [Related]
10. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
[TBL] [Abstract][Full Text] [Related]
11. Identification of vital modules and genes associated with heart failure based on weighted gene coexpression network analysis.
Bian W; Wang Z; Li X; Jiang XX; Zhang H; Liu Z; Zhang DM
ESC Heart Fail; 2022 Apr; 9(2):1370-1379. PubMed ID: 35128826
[TBL] [Abstract][Full Text] [Related]
12. Common Core Genes Play Vital Roles in Gastric Cancer With Different Stages.
Yu Z; Liang C; Tu H; Qiu S; Dong X; Zhang Y; Ma C; Li P
Front Genet; 2022; 13():881948. PubMed ID: 35938042
[No Abstract] [Full Text] [Related]
13. Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer.
Bi D; Ning H; Liu S; Que X; Ding K
Comput Biol Chem; 2015 Jun; 56():71-83. PubMed ID: 25889321
[TBL] [Abstract][Full Text] [Related]
14. Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer.
Uddin MN; Wang X
Breast Cancer; 2022 May; 29(3):541-561. PubMed ID: 35020130
[TBL] [Abstract][Full Text] [Related]
15. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
17. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
18. GOLM1 predicts poor prognosis of patients with NSCLC and is associated with the proliferation and chemo-sensitivity of cisplatin in NSCLC cells: bioinformatics analysis and laboratory validation.
Zhao M; Li X; Chen X
J Bioenerg Biomembr; 2021 Apr; 53(2):177-189. PubMed ID: 33538941
[TBL] [Abstract][Full Text] [Related]
19. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics Analysis of Choriocarcinoma-Related MicroRNA-Transcription Factor-Target Gene Regulatory Networks and Validation of Key miRNAs.
Peng X; Zhang Z; Mo Y; Liu J; Wang S; Liu H
Onco Targets Ther; 2021; 14():3903-3919. PubMed ID: 34234459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
